Regentis Biomaterials Ltd. (RGNT)

Regentis Biomaterials Ltd. (RGNT) is a Medical Instruments & Supplies company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $10.3M; returns 1 day -8.6%, 1 week -14.1%.

Regentis Biomaterials Ltd. is a regenerative medicine company specializing in tissue repair solutions through its proprietary Gelrin technology platform. The company's flagship product, GelrinC, is a cell-free, off-the-shelf hydrogel implant designed to regenerate damaged articular knee cartilage through a single, 10-minute surgical procedure.

Groups RGNT belongs to

• Recent IPOs
• Israel Companies
• Regenerative Medicine
• Biotechnology
• Medical Devices
• Orthopedics
• Clinical Stage Biopharma
• Healthcare Equipment
• Healthcare
• Minimally Invasive Surgery

RGNT financial model: income statement, cash flow and balance sheet